Angiogenesis as a predictor of long-term survival for patients with node-negative breast cancer

Journal of the National Cancer Institute

Volumn 88, Issue 23, 1996, Pages 1764-1769

  Heimann, Ruth ^a   Ferguson, Donald ^b   Powers, Claire ^b   Recant, Wendy M ^b   Weichselbaum, Ralph R ^b   Hellman, Samuel ^b  

^a UNIVERSITY OF CHICAGO   (United States)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; AGED; ANGIOGENESIS; ARTICLE; BREAST CANCER; CANCER STAGING; CANCER SURVIVAL; DIAGNOSTIC VALUE; HUMAN; MAJOR CLINICAL STUDY; RISK ASSESSMENT; TUMOR BLOOD FLOW;

EID: 0029830557     PISSN: 00278874     EISSN: None     Source Type: Journal    
DOI: 10.1093/jnci/88.23.1764     Document Type: Article

References (29)

1. Hellman S. Karnofsky Memorial Lecture. Natural history of small breast cancers [see comment citation in Medline]. J Clin Oncol 1994;12:2229-34.
2. Quiet CA, Ferguson DJ, Weichselbaum RR, Hellman S. Natural history of node-negative breast cancer: a study of 826 patients with long-term follow up [see comment citation in Medline]. J Clin Oncol 1995;13:1144-51.
3. Rosen PR, Groshen S, Saigo PE, Kinne DW, Hellman S. A long-term follow-up study of survival in stage I (T1N0M0) and stage II (T1N1M0) breast carcinoma. J Clin Oncol 1989;7:355-66.
4. Weidner N, Semple JP, Welch WR, Folkman J. Tumor angiogenesis and metastasis - correlation in invasive breast carcinoma. N Engl J Med 1991;324:1-8.
5. Gasparini G, Weidner N, Bevilacqua P, Maluta S, Dalla Palma P, Caffo O, et al. Tumor microvessel density, p53 expression, tumor size, and peritumoral lymphatic vessel invasion are relevant prognostic markers in node-negative breast carcinoma [see comment citation in Medline]. J Clin Oncol 1994;12: 454-66.
6. Ferguson DJ, Meier P, Karisson T, Dawson PJ, Straus FH, Lowenstein FE. Staging of breast cancer and survival rates. An assessment based on 50 years of experience with radical mastectomy. JAMA 1982;248:1337-41.
7. Kaplan EL, Meier P. Nonparametric estimation from incomplete observations. J Am Stat Assoc 1958;53:457-81.
8. Fisher ER, Redmond C, Fisher B. Histologic grading of breast cancer. Pathol Annu 1980; 15:239-51.
9. Weidner N, Folkman J, Pozza F, Bevilacqua P, Allred EN, Moore DH, et al. Tumor angiogenesis: a new significant and independent prognostic indicator in early-stage breast car-cinoma [see comment citations in Medline]. J Natl Cancer Inst 1992;84:1875-87.
10. Gasparini G, Harris AL. Clinical importance of the determination of tumor angiogenesis in breast carcinoma: much more than a new prognostic tool. J Clin Oncol 1995;13:765-82.
11. Mantel N. Evaluation of survival data and two new rank order statistics arising in its consideration. Cancer Chemother Reports 1966; 50:163-70.
12. Cox DR, Oakes D. Analysis of survival data. London: Chapman & Hall, 1984.
13. Selvin S. Practical biostatistical methods. Belmont (CA): Wadsworth Publishing Co, 1995.
14. Folkman J. Tumor angiogenesis. In: Mendelsohn J, Howley P, Israel A, et al., editors. The molecular basis of cancer. Philadelphia: Saunders, 1995:206-24.
15. Liotta LA, Kleinerman J, Saidel GM. Quantitative relationships of intravascular tumor cells, tumor vessels, and pulmonary metastases following tumor implantation. Cancer Res 1974;34:997-1004.
16. Bosari S, Lee AK, DeLellis RA, Wiley BD, Heatley GJ, Silverman ML. Microvessel quantitation and prognosis in invasive breast carcinoma. Hum Pathol 1992;23:755-61.
17. Horak ER, Leek R, Klenk N, LeJeune S, Smith K, Stuart N, et al. Angiogenesis, assessed by platelet/endothelial cell adhesion molecule antibodies, as indicator of node metastases and survival in breast cancer. Lancet 1992;340:1120-4.
18. Toi M, Kashitani J, Tominaga T. Tumor angiogenesis is an independent prognostic indicator in primary breast carcinoma. Int J Cancer 1993;55:371-4.
19. Ogawa Y, Chung YS, Nakata ST, Takatsuka S, Maeda K, Sawada T, et al. Microvessel quantitation in invasive breast cancer by staining for factor VIII-related antigen. Br J Cancer 1995;71:1297-301.
20. Obermair A, Kurz C, Czerwenka K, Thoma M, Kaider A, Wagner T, et al. Microvessel density and vessel invasion in lymph-node-negative breast cancer: effect on recurrence-free survival. Int J Cancer 1995;62:126-31.
21. Miliaras D, Kamas A, Kalekou H. Angiogenesis in invasive breast carcinoma: is it associated with parameters of prognostic significance? Histopathology 1995;26:165-9.
22. Van Hoef ME, Knox WF, Dhesi SS, Howell A, Schor AM. Assessment of tumor vascularity as a prognostic factor in lymph node negative invasive breast cancer. Eur J Cancer 1993;29A:1141-5.
23. Axelsson K, Ljung BM, Moore DH 2nd, Thor AD, Chew KL, Edgerton SM, et al. Tumor angiogenesis as a prognostic assay for invasive ductal breast carcinoma [see comment citations in Medline]. J Natl Cancer Inst 1995;87: 997-1008.
24. Rosen PR, Groshen S, Saigo PE, Kinne DW, Hellman S. A long-term follow-up study of survival in stage I (T1N0M0) and stage II (T1N1M0) breast carcinoma. J Clin Oncol 1989;7:355-66.
25. Gasparini G, Harris AL. Clinical importance of the determination of tumor angiogenesis in breast carcinoma: much more than a new prognostic tool. J Clin Oncol 1995;13:765-82.
26. Wang JM, Kumar S, Pye D, Haboubi N, al-Nakib L. Breast carcinoma: comparative study of tumor vasculature using two endothelial cell markers. J Natl Cancer Inst 1994;86:386-8.
27. Nickoloff BJ. The human progenitor cell antigen (CD34) is localized on endothelial cells, dermal dendritic cells, and perifollicular cells in formalin-fixed normal skin, and on proliferating endothelial cells and stromal spindle-shaped cells in Kaposi's sarcoma. Arch Dermatol 1991;127:523-9.
28. Ramani P, Bradley NJ, Fletcher CD. QBEND/10, a new monclonal antibody to endothelium: assessment of its diagnostic utility in paraffin sections. Histopathology 1990;17: 237-42.
29. Vartanian RK, Weidner N. Correlation of intratumoral endothelial cell proliferation with microvessel density (tumor angiogenesis) and tumor cell proliferation in breast carcinoma. Am J Pathol 1994;144:1188-94.